NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 128 filers reported holding NEWLINK GENETICS CORP in Q3 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,415,000 | -34.3% | 507,273 | 0.0% | 0.02% | -41.9% |
| Q1 2018 | $3,678,000 | -55.0% | 507,273 | -49.6% | 0.03% | -56.3% |
| Q4 2017 | $8,169,000 | -20.3% | 1,007,273 | 0.0% | 0.07% | -14.5% |
| Q3 2017 | $10,254,000 | +179.0% | 1,007,273 | +101.5% | 0.08% | +159.4% |
| Q2 2017 | $3,675,000 | – | 500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |